Ticker ETNB – 89bio – sales, description, marketcap – Tickerday.com

ETNB

89bio

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 508.48M; Volume: 219.99K; AvgVol 3m: 173.77K; Beta: –;

Cost estimate:

P/E: –; EPS: -4.96; EPS growth quarter/prev quarter: 47.00%;

EPS growth this year: -210.60%; EPS growth past 5 years: ;

EPS ttm: -4.57;

P/S: ; P/B: 4.70; P/Cashflow: 6.26; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -86.70%; ROE – return on equity: -130.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: ; Insider Transactions:;

Institutional Ownership: 71.90%; Institutional Transactions: -0.32%;

Data update: 07.10.2020.